Opioid tolerance and the emergence of new opioid receptor-coupled signaling

A R Gintzler1, S Chakrabarti

  • 1Department of Biochemistry, State University of New York Health Science Center at Brooklyn, 11203, USA. agintzler@netmail.hscbklyn.edu

Insights

Opioid tolerance involves more than reduced receptor function; it also stems from altered signaling pathways. Chronic morphine exposure shifts cellular signaling, revealing the adaptive plasticity of opioid systems.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Chronic opioid exposure induces cellular adaptations like reduced receptor availability and G-protein function, traditionally viewed as opioid desensitization.
  • Emerging evidence suggests opioid tolerance is also driven by qualitative alterations in opioid signaling pathways.

Purpose of the Study:

  • To review evidence indicating that opioid tolerance results from both impaired receptor functionality and modified downstream signaling consequences.
  • To explore the molecular underpinnings of altered opioid signaling, focusing on changes in effector molecules coupled to the opioid receptor/G-protein pathway.

Main Methods:

  • Review of existing literature on cellular adaptations to chronic opioid exposure.
  • Analysis of molecular changes in opioid receptor/G-protein signaling pathways, including adenylyl cyclase activity and phosphorylation states.

Main Results:

  • Chronic morphine exposure leads to upregulation and increased phosphorylation of adenylyl cyclase type II isoforms.
  • A significant shift in opioid receptor/G-protein signaling occurs, moving from predominantly inhibitory Gialpha to stimulatory Gbetagamma subunits.
  • These adaptations highlight the plasticity of opioid signal transduction mechanisms.

Conclusions:

  • Opioid tolerance is a complex phenomenon involving both desensitization and altered signaling pathways.
  • Chronic morphine exposure induces adaptive changes in cellular signaling, enabling new signaling strategies and demonstrating the dynamic nature of opioid systems.

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...